Sunshine Biopharma (SBFM) Short-term Investments (2019 - 2025)

Sunshine Biopharma's (SBFM) quarterly Short-term Investments came in at $70457.0 in Q1 2025, up 828.29% on a QoQ basis from $7590.0 in Q3 2022.

Sunshine Biopharma (SBFM) Short-term Investments (2019 - 2025) Analysis & Trends

Sunshine Biopharma (SBFM) has 5 years of Short-term Investments data on file, last reported at $70457.0 in Q1 2025.

Quarterly Short-term Investments changed N/A year-over-year to $70457.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $70457.0 (changed N/A YoY) and the FY2021 annual result came in at $7590.0, changed 0.0% from the prior year.
Short-term Investments grew to $70457.0 in Q1 2025, from $7590.0 in the prior quarter.
In the past five years, Short-term Investments ranged from a high of $70457.0 in Q1 2025 to a low of $7590.0 in Q1 2021.
A 3-year average of $15448.4 and a median of $7590.0 in 2021 frame the typical range for Short-term Investments.
The widest YoY moves for Short-term Investments: up 0.0% in 2021, down 0.0% in 2021.
Tracing SBFM's Short-term Investments over 3 years: stood at $7590.0 in 2021, then changed by 0.0% to $7590.0 in 2022, then jumped by 828.29% to $70457.0 in 2025.
The last three Short-term Investments figures came in at $70457.0 (Q1 2025), $7590.0 (Q3 2022), and $7590.0 (Q2 2022), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	44.51 Bn	43.55 Bn	-
2	Teva Pharmaceutical Industries	43.52 Bn	39.86 Bn	2.15 Bn
3	Zoetis	32.43 Bn	30.75 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn
5	United Therapeutics	21.87 Bn	19.21 Bn	683.80 Mn
6	Viatris	18.98 Bn	18.09 Bn	1.46 Bn
7	Neurocrine Biosciences	15.43 Bn	15.04 Bn	935.80 Mn
8	Elanco Animal Health	12.02 Bn	11.49 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-
10	Sunshine Biopharma	1.60 Mn	-12.15 Mn	2.43 Mn

Download Data